The client is focused on bringing high quality pharmaceuticals to the UK market. The brand is a sign of quality that can be trusted by healthcare professionals. They produce GMP compliant products in their ever-expanding portfolio. A strong pipeline and the portfolio covering several therapeutic areas including analgesic and erectile dysfunction.

Client is engaged in producing high quality generics as well as health supplements (multi vitamins) with a keen focus on quality products and building a brand preference in the long run.

(A) They wanted to become the leading generics pharmaceutical player (manufacturing & distribution) in East Africa and Gulf Cooperation Council. The core idea dealt with providing millions of patients in under-developed/ developing countries with medicines produced at the highest quality standards at affordable prices.

Due to the nature of generics, ample competition and buyer concentration were few of the key issues handled.

Diversity of rivals was also a hurdle but the audits also showcased wider competencies within the firm to leverage future growth.

Strategic audit to better understand the internal competencies and a complete competitive landscape to ascertain external factors. From macro indicators and socio-economic parameters to supplier and white space analysis was thoroughly conducted.

Evaluation of economic situation along with pharma specific indicators highlighted key insights like the purchasing parity, brand preferences, etc.

Based on the insights generated, planning roadmap articulating the resource requirements is laid out. Frameworks for strategic monitoring are also suggested to ensure efficient implementation and maximum returns